N Katakami, T Mita, H Yoshii, T Shiraiwa, T Yasuda , Y Okada, A Kurozumi, M Hatazaki, H Kaneto, T Osonoi, T Yamamoto, N Kuribayashi, K Maeda, H Yokoyama, K Kosugi1, K Ohtoshi, I Hayashi, S Sumitani1, M Tsugawa, K Ryomoto, K Kato, T Nakamura, S Kawashima, Y Sato, H Watada and I Shimomura1 on behalf of the UTOPIA study investigators: Tofoglifozin long-term efects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial. Cardiovascular Diabetology, 22 ; 143, 2023.